This inventor holds 35 USPTO granted patents, primarily in Cancer Therapeutics. Top assignees: Eli Lilly and Company, Joslin Diabetes Center, Inc.. Active years: 1996-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hamberg, DE (2000)
- Indianapolis, IN (US) (1996 - 2002)
- Antioch, IL (US) (2002)
Company Filing History:
35 out of 4,517 
1 out of 76 
Years Active: 1996-2002
Areas of Expertise:
Title: Michael R. Jirousek: Innovator in Medical Therapeutics
Introduction: Michael R. Jirousek, based in Indianapolis, Indiana, is a prominent inventor with an impressive portfolio of 35 patents. His work primarily focuses on innovative therapeutic methods and compounds aimed at improving clinical outcomes for various medical conditions.
Latest Patents: Jirousek's latest contributions to the field of medicine include his patent on "Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy." This invention presents a method for treating neoplasms using a selective PKC inhibitor, specifically targeting the β-isozyme to improve the effectiveness of both oncolytic agents and radiation therapy. Another significant patent encompasses "Hypoglycemic imidazoline compounds," which details novel imidazoline compounds effective for treating diabetes and metabolic disorders, along with their pharmaceutical compositions and preparation processes.
Career Highlights: Throughout his career, Jirousek has made substantial advancements in medical science while working with renowned organizations. He has notably contributed to Eli Lilly and Company, where his research has influenced various pharmaceutical developments. Additionally, his association with the Joslin Diabetes Center, Inc. highlights his commitment to addressing diabetes and related healthcare challenges.
Collaborations: Collaboration has played a vital role in Jirousek's career. He has worked alongside esteemed colleagues such as John H. McDonald, III, and William F. Heath, Jr. Their combined expertise has undoubtedly fostered innovation and has helped drive many of Jirousek's significant medical advancements.
Conclusion: Michael R. Jirousek's innovative spirit and dedication to improving medical therapies through his inventions underscore his impact in the field of healthcare. His patents reflect a commitment to enhancing patient outcomes and expanding the frontiers of medical research. As a distinguished inventor, he continues to inspire many in the realm of medical science and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile